[1]
DIamantopoulos PT(2017)Late-onset nivolumab-mediated pneumonitis in a patient with melanoma and multiple immune-related adverse events. Melanoma Research 27 391-395
[1]
DIamantopoulos PT(2017)Late-onset nivolumab-mediated pneumonitis in a patient with melanoma and multiple immune-related adverse events. Melanoma Research 27 391-395